Nicole Grogg-Hotzer & family (#2871)
- $ 1 B
- Pharmaceuticals
- Switzerland
- F
- 53 Years
'A form of double taxation': Are management fees on new houses quietly getting out of control?
Trump Official Blames Biden Admin for Economic ‘Mess’ — As Resurfaced Clip Shows Him Saying Trump Would Own the Economy By 2026
Is Precigen, Inc. (PGEN) A Good Stock To Buy Now?
Is Transocean Ltd. (RIG) A Good Stock To Buy Now?
Tesla is selling Chinese-made cars in Canada to escape the tariffs that both China and America imposed on it
Insecurity didn’t start with Tinubu, group defends president’s security record
Vibrating pillow sleeve warns deaf sleepers of burglars and fires
How Kepler built verifiable AI for financial services with Claude
Is ASML Holding N.V. (ASML) A Good Stock To Buy Now?
5-Letter Words Ending in ‘Y’ to Help You Improve Your Wordle Skills
About Me
Nicole Grogg-Hotzer is the daughter of Peter Grogg, founder of Swiss biochemical company Bachem Holding AG. Peter Grogg, who died in 2025, started the business in 1971 and served as CEO until 2002, and chairman until 2012. Grogg, along with her billionaire sister and mother, all serve on the board of the family's asset management firm Ingro Finanz AG. Bachem AG develops and manufactures active pharmaceutical ingredients, including peptides, amino acid derivatives and other organic molecules. The family controls about 58% of Bachem as well as shares in Swiss electrical engineering company Burkhalter Holding and chemical maker Dottikon.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Nicole Grogg-Hotzer & family’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Nicole Grogg-Hotzer & family’s net worth journey over the years, highlighting key growth phases and financial milestones.
© Iconic Billionaires